BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31093997)

  • 1. Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland.
    Hyun JJ; Rose JB; Alseidi AA; Biehl TR; Helton S; Coy DL; Kozarek RA; Rocha FG
    J Surg Oncol; 2019 Aug; 120(2):262-269. PubMed ID: 31093997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population.
    Tan Q; Chen C; Wang Z; Zhang H; Liu X; Ke N
    Eur J Radiol; 2023 Aug; 165():110952. PubMed ID: 37421772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
    Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
    Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail.
    Fukami Y; Kaneoka Y; Maeda A; Takayama Y; Onoe S
    Int J Surg; 2016 Nov; 35():64-68. PubMed ID: 27646614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common Hepatic Artery Abutment or Encasement Is an Adverse Prognostic Factor in Patients with Borderline and Unresectable Pancreatic Cancer.
    Kozak GM; Epstein JD; Deshmukh SP; Scott BB; Keith SW; Lavu H; Yeo CJ; Winter JM
    J Gastrointest Surg; 2018 Feb; 22(2):288-294. PubMed ID: 29139084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
    Jeune F; Collard M; Augustin J; Guedj N; Marchese U; Rouquette A; Cunha AS; Sebagh M; Pessaux P; Avérous G; Wagner M; Bachet JB; Vaillant JC; Sauvanet A; Gaujoux S
    Surgery; 2024 Apr; 175(4):1111-1119. PubMed ID: 38071135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of radiological and pathological splenic vein involvement in patients with resectable pancreatic body or tail cancer.
    Kuriyama N; Mizuno S; Sakamoto T; Fujimura Y; Yuge T; Noguchi D; Ito T; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Nagata M; Usui M; Kishiwada M
    Langenbecks Arch Surg; 2024 Jan; 409(1):39. PubMed ID: 38224370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Echo-guided spleen-preserving resection of the pancreas tail for pancreatic intraductal papillary mucinous neoplasms].
    De Raffele E; Mirarchi M; Vaccari S; Santini D; Calculli L; Pendino GM; Cola B
    Chir Ital; 2009; 61(5-6):667-77. PubMed ID: 20380276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC; Klimstra DS; Brennan MF
    Ann Surg; 1996 Mar; 223(3):273-9. PubMed ID: 8604907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.
    Crippa S; Cirocchi R; Maisonneuve P; Partelli S; Pergolini I; Tamburrino D; Aleotti F; Reni M; Falconi M
    Eur J Surg Oncol; 2018 Jan; 44(1):24-30. PubMed ID: 29183639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative imaging for resectable periampullary cancer: clinicopathologic implications of reported radiographic findings.
    Fong ZV; Tan WP; Lavu H; Kennedy EP; Mitchell DG; Koniaris LG; Sauter PK; Rosato EL; Yeo CJ; Winter JM
    J Gastrointest Surg; 2013 Jun; 17(6):1098-106. PubMed ID: 23553385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.
    Bae JS; Kim JH; Joo I; Chang W; Han JK
    Eur Radiol; 2019 Jul; 29(7):3714-3724. PubMed ID: 30899975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
    Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
    Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Routine Splenectomy Justified for All Left-Sided Pancreatic Cancers? Histological Reappraisal of Splenic Hilar Lymphadenectomy.
    Collard M; Marchese T; Guedj N; Cauchy F; Chassaing C; Ronot M; Dokmak S; Soubrane O; Sauvanet A
    Ann Surg Oncol; 2019 Apr; 26(4):1071-1078. PubMed ID: 30607766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of splenic pathology in distal pancreatectomies.
    Onesti JK; Chung MH; Jain DH; Stafford MM; Attawala PP
    Pancreatology; 2013; 13(6):625-8. PubMed ID: 24280581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.